Prostaglandin E2 induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2563-2573

  Ganesh, Kasturi ^a   Das, Amitava ^a   Dickerson, Ryan ^a   Khanna, Savita ^a   Parinandi, Narasimham L ^a   Gordillo, Gayle M ^a   Sen, Chandan K ^a   Roy, Sashwati ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN E2; AXL TYROSINE KINASE RECEPTOR; BUTAPROST; CYCLIC AMP; FORSKOLIN; HERBIMYCIN A; INDOMETACIN; INTERLEUKIN 1BETA; MESSENGER RNA; ONCOSTATIN M; POLYVINYL ALCOHOL; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; RECOMBINANT CYTOKINE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ABDOMINAL INJURY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CHRONIC WOUND; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; LEG INJURY; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; VACUUM ASSISTED CLOSURE; WOUND CLOSURE; WOUND FLUID; WOUND HEALING;

ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHRONIC DISEASE; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MACROPHAGES; MALE; MICE; MIDDLE AGED; ONCOSTATIN M; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; WOUND INFECTION;

EID: 84865405223     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102762     Document Type: Article

References (65)

1. Sen, C. K., G. M. Gordillo, S. Roy, R. Kirsner, L. Lambert, T. K. Hunt, F. Gottrup, G. C. Gurtner, and M. T. Longaker. 2009. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 17: 763-771.
2. Leibovich, S. J., and R. Ross. 1975. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 78: 71-100.
3. Lucas, T., A. Waisman, R. Ranjan, J. Roes, T. Krieg, W. Müller, A. Roers, and S. A. Eming. 2010. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184: 3964-3977.
4. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
5. Stout, R. D., and J. Suttles. 2004. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76: 509-513.
6. Daley, J. M., S. K. Brancato, A. A. Thomay, J. S. Reichner, and J. E. Albina. 2010. The phenotype of murine wound macrophages. J. Leukoc. Biol. 87: 59-67.
7. Brancato, S. K., and J. E. Albina. 2011. Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 178: 19-25.
8. Goren, I., H. Kämpfer, E. Müller, D. Schiefelbein, J. Pfeilschifter, and S. Frank. 2006. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J. Invest. Dermatol. 126: 628-637.
9. Tanaka, M., and A. Miyajima. 2003. Oncostatin M, a multifunctional cytokine. Rev. Physiol. Biochem. Pharmacol. 149: 39-52.
10. Gómez-Lechón, M. J. 1999. Oncostatin M: signal transduction and biological activity. Life Sci. 65: 2019-2030.
11. Roy, S., R. Dickerson, S. Khanna, E. Collard, U. Gnyawali, G. M. Gordillo, and C. K. Sen. 2011. Particulate b-glucan induces TNF-a production in wound macrophages via a redox-sensitive NF-kb-dependent pathway. Wound Repair Regen. 19: 411-419.
12. Khanna, S., S. Biswas, Y. Shang, E. Collard, A. Azad, C. Kauh, V. Bhasker, G. M. Gordillo, C. K. Sen, and S. Roy. 2010. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 5: e9539.
13. Vairo, G., and J. A. Hamilton. 1985. CSF-1 stimulates Na+K+-ATPase mediated 86Rb+ uptake in mouse bone marrow-derived macrophages. Biochem. Biophys. Res. Commun. 132: 430-437.
14. Davies, J. Q., and S. Gordon. 2005. Isolation and culture of murine macrophages. In Basic Cell Culture Protocols. C. D. Helgason, and C. L. Miller, eds. Humana Press, Totowa, NJ, p. 91-103.
15. Roy, S., S. Khanna, K. Nallu, T. K. Hunt, and C. K. Sen. 2006. Dermal wound healing is subject to redox control. Mol. Ther. 13: 211-220.
16. Galiano, R. D., J. Michaels, V, M. Dobryansky, J. P. Levine, and G. C. Gurtner. 2004. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 12: 485-492.
17. Roy, S., S. Khanna, C. Rink, S. Biswas, and C. K. Sen. 2008. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol. Genomics 34: 162-184.
18. Roy, S., S. Khanna, D. E. Kuhn, C. Rink, W. T. Williams, J. L. Zweier, and C. K. Sen. 2006. Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol. Genomics 25: 364-374.
19. Roy, S., S. Khanna, P. E. Yeh, C. Rink, W. B. Malarkey, J. Kiecolt-Glaser, B. Laskowski, R. Glaser, and C. K. Sen. 2005.Wound site neutrophil transcriptome in response to psychological stress in young men. Gene Expr. 12: 273-287.
20. Roy, S., D. Patel, S. Khanna, G. M. Gordillo, S. Biswas, A. Friedman, and C. K. Sen. 2007. Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc. Natl. Acad. Sci. USA 104: 14472-14477.
21. Roy, S., S. Khanna, W. A. Wallace, J. Lappalainen, C. Rink, A. J. Cardounel, J. L. Zweier, and C. K. Sen. 2003. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J. Biol. Chem. 278: 47129-47135.
22. Verducci, J. S., V. F. Melfi, S. Lin, Z. Wang, S. Roy, and C. K. Sen. 2006. Microarray analysis of gene expression: considerations in data mining and statistical treatment. Physiol. Genomics 25: 355-363.
23. Roy, S., S. Khanna, A. Azad, R. Schnitt, G. He, C. Weigert, H. Ichijo, and C. K. Sen. 2010. Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts. Cardiovasc. Res. 87: 647-655.
24. Repovic, P., and E. N. Benveniste. 2002. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J. Neurosci. 22: 5334-5343.
25. Hamberg, M., and B. Samuelsson. 1971. On the metabolism of prostaglandins E 1 and E 2 in man. J. Biol. Chem. 246: 6713-6721.
26. Repovic, P., K. Mi, and E. N. Benveniste. 2003. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 42: 433-446.
27. Stenson, W. F., and C. W. Parker. 1980. Prostaglandins, macrophages, and immunity. J. Immunol. 125: 1-5.
28. Ushikubi, F., M. Hirata, and S. Narumiya. 1995. Molecular biology of prostanoid receptors; an overview. J. Lipid Mediat. Cell Signal. 12: 343-359.
29. Cherukuri, D. P., X. B. Chen, A. C. Goulet, R. N. Young, Y. Han, R. L. Heimark, J. W. Regan, E. Meuillet, and M. A. Nelson. 2007. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells. Exp. Cell Res. 313: 2969-2979.
30. Regan, J. W. 2003. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74: 143-153.
31. Ma, Y., R. J. Streiff, J. Liu, M. J. Spence, and R. E. Vestal. 1999. Cloning and characterization of human oncostatin M promoter. Nucleic Acids Res. 27: 4649-4657.
32. Mollinedo, F., C. Gajate, A. Tugores, I. Flores, and J. R. Naranjo. 1993. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. Biochem. J. 294: 137-144.
33. Holland, S. J., A. Pan, C. Franci, Y. Hu, B. Chang, W. Li, M. Duan, A. Torneros, J. Yu, T. J. Heckrodt, et al. 2010. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 70: 1544-1554.
34. Falanga, V. 1992. Growth factors and chronic wounds: the need to understand the microenvironment. J. Dermatol. 19: 667-672.
35. Schultz, G. S., J. M. Davidson, R. S. Kirsner, P. Bornstein, and I. M. Herman. 2011. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen. 19: 134-148.
36. Moussai, D., H. Mitsui, J. S. Pettersen, K. C. Pierson, K. R. Shah, M. Suárez-Fariñas, I. R. Cardinale, M. J. Bluth, J. G. Krueger, and J. A. Carucci. 2011. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J. Invest. Dermatol. 131: 229-236.
37. Stearman, R. S., L. Dwyer-Nield, M. C. Grady, A. M. Malkinson, and M. W. Geraci. 2008. A macrophage gene expression signature defines a field effect in the lung tumor microenvironment. Cancer Res. 68: 34-43.
38. Dumas, A., S. Lagarde, C. Laflamme, and M. Pouliot. 2012. Oncostatin M decreases interleukin-1 b secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo. J. Cell. Mol. Med. 16: 1274-1285.
39. David, E., P. Guihard, B. Brounais, A. Riet, C. Charrier, S. Battaglia, F. Gouin, S. Ponsolle, R. L. Bot, C. D. Richards, et al. 2011. Direct anti-cancer effect of oncostatin M on chondrosarcoma. Int. J. Cancer 128: 1822-1835.
40. Huang, F. M., C. H. Tsai, S. F. Yang, and Y. C. Chang. 2009. The upregulation of oncostatin M in inflamed human dental pulps. Int. Endod. J. 42: 627-631.
41. Albasanz-Puig, A., J. Murray, M. Preusch, D. Coan, M. Namekata, Y. Patel, Z. M. Dong, M. E. Rosenfeld, and E. S. Wijelath. 2011. Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis. Atherosclerosis 216: 292-298.
42. Zeaiter, Z., H. Diaz, M. Stein, and H. Q. Huynh. 2011. Helicobacter pylori induces expression and secretion of oncostatin M in macrophages in vitro. Dig. Dis. Sci. 56: 689-697.
43. Kastl, S. P., W. S. Speidl, K. M. Katsaros, C. Kaun, G. Rega, A. Assadian, G.W. Hagmueller, M. Hoeth, R. de Martin, Y. Ma, et al. 2009. Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation. Blood 114: 2812-2818.
44. Kastl, S. P., W. S. Speidl, C. Kaun, K. M. Katsaros, G. Rega, T. Afonyushkin, V. N. Bochkov, P. Valent, A. Assadian, G. W. Hagmueller, et al. 2008. In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation. Arterioscler. Thromb. Vasc. Biol. 28: 498-503.
45. Ricciotti, E., and G. A. FitzGerald. 2011. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31: 986-1000.
46. Van Elssen, C. H., J. Vanderlocht, T. Oth, B. L. Senden-Gijsbers, W. T. Germeraad, and G. M. Bos. 2011. Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation. Blood 118: 2473-2482.
47. Gomez, P. F., M. H. Pillinger, M. Attur, N. Marjanovic, M. Dave, J. Park, C. O. Bingham, III, H. Al-Mussawir, and S. B. Abramson. 2005. Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J. Immunol. 175: 6924-6930.
48. Talwar, M., T. N. Moyana, B. Bharadwaj, and L. K. Tan. 1996. The effect of a synthetic analogue of prostaglandin E2 on wound healing in rats. Ann. Clin. Lab. Sci. 26: 451-457.
49. Baxter, C. R. 1994. Immunologic reactions in chronic wounds. Am. J. Surg. 167 (1A): 12S-14S.
50. Egg, D. 1984. Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. Z. Rheumatol. 43: 89-96.
51. Hasegawa, S., T. Ichiyama, F. Kohno, Y. Korenaga, A. Ohsaki, R. Hirano, Y. Haneda, R. Fukano, and S. Furukawa. 2010. Prostaglandin E2 suppresses beta1-integrin expression via E-prostanoid receptor in human monocytes/macrophages. Cell. Immunol. 263: 161-165.
52. Suzawa, T., C. Miyaura, M. Inada, T. Maruyama, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and T. Suda. 2000. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141: 1554-1559.
53. Nataraj, C., D. W. Thomas, S. L. Tilley, M. T. Nguyen, R. Mannon, B. H. Koller, and T. M. Coffman. 2001. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108: 1229-1235.
54. Sharif, M. N., D. Sosic, C. V. Rothlin, E. Kelly, G. Lemke, E. N. Olson, and L. B. Ivashkiv. 2006. Twist mediates suppression of inflammation by type I IFNs and Axl. J. Exp. Med. 203: 1891-1901.
55. Weinger, J. G., C. F. Brosnan, O. Loudig, M. F. Goldberg, F. Macian, H. A. Arnett, A. L. Prieto, V. Tsiperson, and B. Shafit-Zagardo. 2011. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis. J. Neuroinflammation 8: 49.
56. Konishi, A., T. Aizawa, A. Mohan, V. A. Korshunov, and B. C. Berk. 2004. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J. Biol. Chem. 279: 28766-28770.
57. Mudduluru, G., J. H. Leupold, P. Stroebel, and H. Allgayer. 2010. PMA upregulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells. Biol. Cell 103: 21-33.
58. Sayan, A. E., R. Stanford, R. Vickery, E. Grigorenko, J. Diesch, K. Kulbicki, R. Edwards, R. Pal, P. Greaves, I. Jariel-Encontre, et al. 2012. Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL. Oncogene 31: 1493-1503.
59. Hess, J., P. Angel, and M. Schorpp-Kistner. 2004. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117: 5965-5973.
60. Suda, M., K. Tanaka, Y. Sakuma, A. Yasoda, A. Ozasa, J. Fukata, I. Tanaka, S. Narumiya, and K. Nakao. 2000. Prostaglandin E(2) (PGE(2)) induces the cfos and c-jun expressions via the EP(1) subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Calcif. Tissue Int. 66: 217-223.
61. Mechta-Grigoriou, F., D. Gerald, and M. Yaniv. 2001. The mammalian Jun proteins: redundancy and specificity. Oncogene 20: 2378-2389.
62. Wahl, A. F., and P. M. Wallace. 2001. Oncostatin M in the anti-inflammatory response. Ann. Rheum. Dis. 60(Suppl 3): iii75-iii80.
63. Hams, E., C. S. Colmont, V. Dioszeghy, V. J. Hammond, C. A. Fielding, A. S. Williams, M. Tanaka, A. Miyajima, P. R. Taylor, N. Topley, and S. A. Jones. 2008. Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation. J. Immunol. 181: 2174-2180.
64. Drinkwater, S. L., A. Smith, and K. G. Burnand. 2002. What can wound fluids tell us about the venous ulcer microenvironment? Int. J. Low. Extrem. Wounds 1: 184-190.
65. Pentland, A. P., and P. Needleman. 1986. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. Clin. Invest. 77: 246-251.